200 related articles for article (PubMed ID: 28410854)
21. Correlation between tear film osmolarity, dry eye disease, and rheumatoid arthritis.
Schargus M; Wolf F; Tony HP; Meyer-Ter-Vehn T; Geerling G
Cornea; 2014 Dec; 33(12):1257-61. PubMed ID: 25255140
[TBL] [Abstract][Full Text] [Related]
22. Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: correlation with systemic inflammatory markers and oxidative stress, preliminary report.
Shahmohamadnejad S; Vaisi-Raygani A; Shakiba Y; Kiani A; Rahimi Z; Bahrehmand F; Shakiba E; Pourmotabbed T
Clin Biochem; 2015 Jan; 48(1-2):63-9. PubMed ID: 25179377
[TBL] [Abstract][Full Text] [Related]
23. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
[TBL] [Abstract][Full Text] [Related]
24. Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.
Syngle A; Vohra K; Garg N; Kaur L; Chand P
Int J Rheum Dis; 2012 Feb; 15(1):45-55. PubMed ID: 22324946
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
26. Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants.
Inciarte-Mundo J; Ruiz-Esquide V; Hernández MV; Cañete JD; Cabrera-Villalba SR; Ramirez J; Yagüe J; Sanmarti R
Rheumatology (Oxford); 2015 Dec; 54(12):2239-43. PubMed ID: 26242859
[TBL] [Abstract][Full Text] [Related]
27. Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M
Clin Exp Rheumatol; 1998; 16(5):533-40. PubMed ID: 9779299
[TBL] [Abstract][Full Text] [Related]
28. Levels of plasma-soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) are correlated with disease activity in rheumatoid arthritis.
Choi ST; Kang EJ; Ha YJ; Song JS
J Rheumatol; 2012 May; 39(5):933-8. PubMed ID: 22422501
[TBL] [Abstract][Full Text] [Related]
29. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults.
Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H
J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644
[TBL] [Abstract][Full Text] [Related]
30. Thrombin-cleaved osteopontin is increased in urine of patients with rheumatoid arthritis.
Shio K; Kobayashi H; Asano T; Saito R; Iwadate H; Watanabe H; Sakuma H; Segawa T; Maeda M; Ohira H
J Rheumatol; 2010 Apr; 37(4):704-10. PubMed ID: 20156944
[TBL] [Abstract][Full Text] [Related]
31. Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission.
Toldi G; Bekő G; Kádár G; Mácsai E; Kovács L; Vásárhelyi B; Balog A
Clin Chem Lab Med; 2013 Feb; 51(2):327-32. PubMed ID: 22718576
[TBL] [Abstract][Full Text] [Related]
32. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.
Hammer HB; Odegard S; Fagerhol MK; Landewé R; van der Heijde D; Uhlig T; Mowinckel P; Kvien TK
Ann Rheum Dis; 2007 Aug; 66(8):1093-7. PubMed ID: 17234650
[TBL] [Abstract][Full Text] [Related]
33. Serum adenosine deaminase may predict disease activity in rheumatoid arthritis.
Zamani B; Jamali R; Jamali A
Rheumatol Int; 2012 Jul; 32(7):1967-75. PubMed ID: 21461854
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
[TBL] [Abstract][Full Text] [Related]
35. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
van Eijk IC; Tushuizen ME; Sturk A; Dijkmans BA; Boers M; Voskuyl AE; Diamant M; Wolbink GJ; Nieuwland R; Nurmohamed MT
Ann Rheum Dis; 2010 Jul; 69(7):1378-82. PubMed ID: 19919943
[TBL] [Abstract][Full Text] [Related]
36. Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis.
Shen C; Sun XG; Liu N; Mu Y; Hong CC; Wei W; Zheng F
Mol Med Rep; 2015 Feb; 11(2):1528-34. PubMed ID: 25352049
[TBL] [Abstract][Full Text] [Related]
37. Judging disease activity in rheumatoid arthritis by serum free kappa and lambda light chain levels.
Ye Y; Li SL; Xie M; Jiang P; Liu KG; Li YJ
Kaohsiung J Med Sci; 2013 Oct; 29(10):547-53. PubMed ID: 24099109
[TBL] [Abstract][Full Text] [Related]
38. Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.
Hurnakova J; Hulejova H; Zavada J; Hanova P; Komarc M; Mann H; Klein M; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Vencovsky J; Pavelka K; Senolt L
PLoS One; 2017; 12(8):e0183420. PubMed ID: 28832684
[TBL] [Abstract][Full Text] [Related]
39. APRIL Level as a Marker of Disease Activity in Treated Rheumatoid Arthritis Patients: Association with Disease Activity and Anti-CCP Antibody.
Boghdadi G; El-Sokkary RH; Elewa EA; Abbas SF
Egypt J Immunol; 2015 Jun; 22(2):31-39. PubMed ID: 28502142
[TBL] [Abstract][Full Text] [Related]
40. Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis.
Barbosa-Cobos RE; Lugo-Zamudio G; Flores-Estrada J; Becerril-Mendoza LT; Rodríguez-Henríquez P; Torres-González R; Moreno-Eutimio MA; Ramirez-Bello J; Moreno J
Clin Rheumatol; 2018 Apr; 37(4):901-908. PubMed ID: 29256110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]